Matrix metalloproteinases in COPD

European Respiratory Journal

Volumn 39, Issue 1, 2012, Pages 197-209

  Churg, A ^a   Zhou, S ^a   Wright, J L ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Chronic obstructive pulmonary disease; Cigarette smoke; Emphysema; Matrix metalloproteinase 12; Matrix metalloproteinases; Small airway remodelling

Indexed keywords

AZ 11557272; CP 471474; GELATINASE A; GELATINASE B; GROWTH FACTOR; ILOMASTAT; INTERSTITIAL COLLAGENASE; MACROPHAGE ELASTASE; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; RS 113456; RS 1329081; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; COLLAGEN;

AIRWAY REMODELING; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; DOWN REGULATION; EMPHYSEMA; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME RELEASE; ENZYME SYNTHESIS; EXPERIMENTAL MODEL; HUMAN; LUNG ALVEOLUS WALL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN SECRETION; PULMONARY HYPERTENSION; REVIEW; TREATMENT RESPONSE; UPREGULATION; ANIMAL; BIOLOGICAL MODEL; BRONCHITIS; C57BL MOUSE; ENZYMOLOGY; INFLAMMATION; METABOLISM; MOUSE; PATHOPHYSIOLOGY; SMOKING; TREATMENT OUTCOME;

ANIMALS; BRONCHITIS; COLLAGEN; EMPHYSEMA; HUMANS; HYPERTENSION, PULMONARY; INFLAMMATION; MATRIX METALLOPROTEINASES; MICE; MICE, INBRED C57BL; MODELS, BIOLOGICAL; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING; TREATMENT OUTCOME;

EID: 84855397703     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00121611     Document Type: Review

References (131)

1. Löffek S, Schilling O, Franzke CW. Biological role of matrix metalloproteinases: a critical balance. Eur Respir J 2011; 38: 191-208.
2. Gueders MM, Foidart J-M, Noel A, et al. Matrix metalloproteinases of MMPs in the respiratory tract: potential implications in asthma and other lung diseases. Eur J Pharmacol 2006; 533: 133-144. (Pubitemid 43340010)
3. Janoff A. Proteases and lung injury. A state-of-the-art minireview. Chest 1983; 83: 54S-58S. (Pubitemid 13084785)
4. Hautamaki RD, Kobayashi DK, Senior RM, et al. Macrophage elastase is required for cigarette smoke-induced emphysema in mice. Science 1997; 277: 2002-2004. (Pubitemid 27449144)
5. Churg A, Cosio M, Wright JL. Mechanisms of cigarette smoke-induced COPD: insights from animal models. Am J Physiol 2008; 294: L612-L631. (Pubitemid 351520094)
6. Vandenbroucke RE, Dejonckheere E, Libert C. A therapeutic role for matrix metalloproteinase inhibitors in lung diseases? Eur Respir J 2011; 38: 1200-1214.
7. Hogg JC, Chu F, Utokaparch S, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004; 350: 2645-2653. (Pubitemid 38787999)
8. Wright JL, Levy RD, Churg A. Pulmonary hypertension in chronic obstructive pulmonary disease: current theories of pathogenesis and their implications for treatment. Thorax 2005; 60: 605-609. (Pubitemid 40966216)
9. Bezerra FS, Valença SS, Pires KM, et al. Long-term exposure to cigarette smoke impairs lung function and increases HMGB-1 expression in mice. Respir Physiol Neurobiol 2011; 177: 120-126.
10. Botelho FM, Nikota J, Bauer C, et al. A mouse GM-CSF receptor antibody attenuates neutrophilia in mice exposed to cigarette smoke. Eur Respir J 2011; 38: 285-294.
11. Pauwels NS, Bracke KR, Maes T, et al. Cigarette smoke induces PTX3 expression in pulmonary veins of mice in an IL-1 dependent manner. Respir Res 2010; 11: 134.
12. Lang CJ, Hansen M, Roscioli E, et al. Dietary zinc mediates inflammation and protects against wasting and metabolic derangement caused by sustained cigarette smoke exposure in mice. Biometals 2011; 24: 23-39.
13. Arunachalam G, Sundar IK, Hwang JW, et al. Emphysema is associated with increased inflammation in lungs of atherosclerosis-prone mice by cigarette smoke: implications in comorbidities of COPD. J Inflamm (Lond) 2010; 22: 7.
14. De Swert KO, Bracke KR, Demoor T, et al. Role of the tachykinin NK1 receptor in a murine model of cigarette smoke-induced pulmonary inflammation. Respir Res 2009; 10: 37.
15. Xu J, Xu F, Wang R, et al. Cigarette smoke-induced hypercapnic emphysema in C3H mice is associated with increases of macrophage metalloelastase and substance P in the lungs. Exp Lung Res 2007; 33: 197-215. (Pubitemid 47057144)
16. Da Hora K, Valença SS, Porto LC. Immunohistochemical study of tumor necrosis factor-α, matrix metalloproteinase-12, and tissue inhibitor of metalloproteinase-2 on alveolar macrophages of BALB/c mice exposed to short-term cigarette smoke. Exp Lung Res 2005; 31: 759-770. (Pubitemid 41831704)
17. Vlahos R, Bozinovski S, Jones JE, et al. Differential protease, innate immunity, and NF-κB induction profiles during lung inflammation induced by subchronic cigarette smoke exposure in mice. Am J Physiol Lung Cell Mol Physiol 2006; 290: L931-L945. (Pubitemid 43725055)
18. Vlahos R, Bozinovski S, Chan SP, et al. Neutralizing granulocyte/ macrophage colony-stimulating factor inhibits cigarette smoke-induced lung inflammation. Am J Respir Crit Care Med 2010; 182: 34-40.
19. Bracke KR, D'hulst AI, Maes T, et al. Cigarette smoke-induced pulmonary inflammation and emphysema are attenuated in CCR6-deficient mice. J Immunol 2006; 177: 4350-4359.
20. Maes T, Bracke KR, Vermaelen KY, et al. Murine TLR4 is implicated in cigarette smoke-induced pulmonary inflammation. Int Arch Allergy Immunol 2006; 141: 354-368. (Pubitemid 44783906)
21. Churg A, Wang R, Wang X, et al. An MMP-9/-12 inhibitor prevents smoke-induced emphysema and small airway remodeling in guinea pigs. Thorax 2007; 62: 706-713. (Pubitemid 47235016)
22. Churg A, Wang X, Wang RD, et al. Alpha1-antitrypsin suppresses TNF-α and MMP-12 production by cigarette smoke-stimulated macrophages. Am J Respir Cell Mol Biol 2007; 37: 144-151. (Pubitemid 47254997)
23. Chen K, Pociask DA, McAleer JP, et al. IL-17RA is required for CCL2 expression, macrophage recruitment, and emphysema in response to cigarette smoke. PLoS One 2011; 6: e20333.
24. Xiong Z, Leme AS, Ray P, et al. CX3CR1+ lung mononuclear phagocytes spatially confined to the interstitium produce TNF-αand IL-6 and promote cigarette smoke-induced emphysema. J Immunol 2011; 186: 3206-3214.
25. Nénan S, Planquois JM, Berna P, et al. Analysis of the inflammatory response induced by rhMMP-12 catalytic domain instilled in mouse airways. Int Immunopharmacol 2005; 5: 511-524. (Pubitemid 40430759)
26. Churg A, Wang RD, Tai H, et al. Macrophage metalloelastase mediates acute cigarette smoke-induced inflammation via tumor necrosis factor-α release. Am J Respir Crit Care Med 2003; 167: 1083-1089. (Pubitemid 36459653)
27. Le Quément C, Guénon I, Gillon JY, et al. MMP-12 induces IL-8/CXCL8 secretion through EGFR and ERK1/2 activation in epithelial cells. Am J Physiol Lung Cell Mol Physiol 2008; 294: L1076-L1084.
28. Le Quément C, Guénon I, Gillon JY, et al. The selective MMP-12 inhibitor, AS111793 reduces airway inflammation in mice exposed to cigarette smoke. Br J Pharmacol 2008; 154: 1206-1215. (Pubitemid 351992055)
29. Senior RM, Griffin GL, Mecham RP. Chemotactic activity of elastin-derived peptides. J Clin Invest 1980; 66: 859-862. (Pubitemid 10060957)
30. Hunninghake GW, Davidson JM, Rennard S, et al. Elastin fragments attract macrophage precursors to diseased sites in pulmonary emphysema. Science 1981; 212: 925-927. (Pubitemid 11120475)
31. Houghton AM, Quintero PA, Perkins DL, et al. Elastin fragments drive disease progression in a murine model of emphysema. J Clin Invest 2006; 116: 753-759. (Pubitemid 43326884)
32. Weathington NM, van Houwelingen AH, et al. A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation. Nat Med 2006; 12: 317-323. (Pubitemid 43355080)
33. Braber S, Overbeek SA, Koelink PJ, et al. CXCR2 antagonists block the N-Ac-PGP-induced neutrophil influx in the airways of mice, but not the production of the chemokine CXCL1. Eur J Pharmacol 2011; 668: 443-449.
34. van Houwelingen AH, Weathington NM, Verweij V, et al. Induction of lung emphysema is prevented by L-arginine-threonine-arginine. FASEB J 2008; 22: 3403-3408.
35. Malik M, Bakshi CS, McCabe K, et al. Matrix metalloproteinase 9 activity enhances host susceptibility to pulmonary infection with type A and B strains of Francisella tularensis. J Immunol 2007; 178: 1013-1020. (Pubitemid 46095174)
36. Snelgrove RJ. Leukotriene A4 hydrolase: an anti-inflammatory role for a proinflammatory enzyme. Thorax 2011; 66: 550-551.
37. Shapiro SD, Goldstein NM, Houghton AM, et al. Neutrophil elastase contributes to cigarette smoke-induced emphysema in mice. Am J Pathol 2003; 163: 2329-2335. (Pubitemid 37466476)
38. Raza SL, Nehring LC, Shapiro SD, et al. Proteinase-activated receptor-1 regulation of macrophage elastase (MMP-12) secretion by serine proteinases. J Biol Chem 2000; 275: 41243-41250. (Pubitemid 32054957)
39. Xu J, Xu F, Barrett E. Metalloelastase in lungs and alveolar macrophages is modulated by extracellular substance P in mice. Am J Physiol Lung Cell Mol Physiol 2008; 295: L162-L170.
40. Kassim SY, Fu X, Liles WC, et al. NADPH oxidase restrains the matrix metalloproteinase activity of macrophages. J Biol Chem 2005; 280: 30201-30205. (Pubitemid 41216199)
41. Sin DD, Pahlavan PS, Man SF. Surfactant protein D: a lung specific biomarker in COPD? Ther Adv Respir Dis 2008; 2: 65-74. (Pubitemid 351472132)
42. Trask BC, Malone MJ, Lum EH, et al. Induction of macrophage matrix metalloproteinase biosynthesis by surfactant protein D. J Biol Chem 2001; 276: 37846-37852.
43. Yoshida M, Whitsett JA. Alveolar macrophages and emphysema in surfactant protein-D-deficient mice. Respirology 2006; 11: Suppl., S37-S40.
44. Lappalainen U, Whitsett JA, Wert SE, et al. Interleukin-1β causes pulmonary inflammation, emphysema, and airway remodeling in the adult murine lung. Am J Respir Cell Mol Biol 2005; 32: 311-318. (Pubitemid 40478306)
45. Vuillemenot BR, Rodriguez JF, Hoyle GW. Lymphoid tissue and emphysema in the lungs of transgenic mice inducibly expressing tumor necrosis factor-a. Am J Respir Cell Mol Biol 2004; 30: 438-448. (Pubitemid 38457177)
46. Morris DG, Huang X, Kaminski N, et al. Loss of integrin αvβ6-mediated TGF-β activation causes MMP12-dependent emphysema. Nature 2003; 422: 169-173. (Pubitemid 36362749)
47. Bonniaud P, Kolb M, Galt T, et al. Smad3 null mice develop airspace enlargement J, are resistant to TGF-β-mediated pulmonary fibrosis. J Immunol 2004; 173: 2099-2108. (Pubitemid 38971648)
48. Imai K, Dalal SS, Chen ES, et al. Human collagenase (matrix metalloproteinase-1. expression in the lungs of patients with emphysema. Am Rev Respir Dis 2001; 163: 786-791. (Pubitemid 32230844)
49. Finlay GA, O'Driscoll LR, Russell KJ, et al. Matrix metalloproteinase expression and production by alveolar macrophages in emphysema. Am J Respir Crit Care Med 1997; 156: 240-247. (Pubitemid 27293196)
50. LaPan P, Brady J, Grierson C, et al. Optimization of total protein and activity assays for the detection of MMP-12 in induced human sputum. BMC Pulm Med 2010; 10: 40.
51. Gosselink JV, Hayashi S, Elliott WM, et al. Differential expression of tissue repair genes in the pathogenesis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010; 181: 1329-1335.
52. Lee SY, Kim MJ, Kang HG, et al. Polymorphisms in matrix metalloproteinase-1, -9 and -12 genes and the risk of chronic obstructive pulmonary disease in a Korean population. Respiration 2010; 80: 133-138.
53. Schirmer H, Basso da Silva L, et al. Matrix metalloproteinase gene polymorphisms: lack of association with chronic obstructive pulmonary disease in a Brazilian population. Genet Mol Res 2009; 8: 1028-1034.
54. Ilumets H, Rytila P, Demedts L, et al. Matrix metalloproteinases -8, -9, and -12 in smokers and patients with stage 0 COPD. Int J COPD 2007; 2: 369-379. (Pubitemid 350110911)
55. Demedts IK, Morel-Montero A, Lebecque S, et al. Elevated MMP-12 protein levels in induced sputum from patients with COPD. Thorax 2006; 61: 196-201.
56. Woodruff PG, Koth LL, Yang YH, et al. A distinctive alveolar macrophage activation state induced by cigarette smoking. Am J Respir Crit Care Med 2005; 172: 1383-1392. (Pubitemid 43069811)
57. Babusyte A, Stravinskaite K, Jeroch J, et al. Patterns of airway inflammation and MMP-12 expression in smokers and ex-smokers with COPD. Respir Res 2007; 8: 81.
58. Wallace AM, Sandford AJ, English JC, et al. Matrix metalloproteinase expression by human alveolar macrophages in relation to emphysema. COPD 2008; 5: 13-23. (Pubitemid 351225520)
59. van Diemen C, Postma D, Siedlinski M, et al. Genetic variation in TIMP1 but not MMPs predict excess FEV1 decline in two general population-based cohorts. Respir Res 2011; 12: 57.
60. Hunninghake GM, Cho MH, Tesfaigzi Y, et al. MMP12, lung function, and COPD in high-risk populations. N Engl J Med 2009; 361: 2599-2608.
61. Haq I, Chappell S, Johnson SR, et al. Association of MMP-12 polymorphisms with severe and very severe COPD: a case control study of MMPs -1, 9 and 12 in a European population. BMC Med Genet 2010; 11: 7.
62. Joos L, He JQ, Shepherdson MB, et al. The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function. Hum Mol Genet 2002; 11: 569-576. (Pubitemid 34257493)
63. Dean RA, Cox JH, Bellac CL, et al. Macrophage-specific metalloelastase (MMP-12) truncates and inactivates ELR+ CXC chemokines and generates CCL2, -7, -8, and -13 antagonists: potential role of the macrophage in terminating polymorphonuclear leukocyte influx. Blood 2008; 112: 3455-3464.
64. Churg A, Zay K, Shay S, et al. Acute cigarette smoke induced connective tissue breakdown requires both neutrophils and macrophage metalloelastase in mice. Am J Respir Cell Mol Biol 2002; 27: 368-374. (Pubitemid 34979296)
65. Houghton AM, Hartzell WO, Robbins CS, et al. Macrophage elastase kills bacteria within murine macrophages. Nature 2009; 460: 637-641.
66. Magnussen H, Watz H, Kirsten A, et al. Safety and tolerability of an oral MMP-9 and -12 inhibitor, AZD1236, in patients with moderate-to-severe COPD: a randomised controlled 6-week trial. Pulm Pharmacol Ther 2011; 24: 563-570.
67. Hogg JC, Nepszy SJ, Macklem PT, et al. Elastic properties of the centrilobular emphysematous space. J Clin Invest 1969; 48: 1306-1312.
68. Cardoso W, Sekhon H, Hyde DM, et al. Collagen and elastin in human pulmonary emphysema. Am Rev Respir Dis 1993; 147: 975-981. (Pubitemid 23093826)
69. Lang MR, Fiaux GW, Gillooly M, et al. Collagen content of alveolar wall tissue in emphysematous and non-emphysematous lungs. Thorax 1994; 49: 319-326. (Pubitemid 24149193)
70. Lang MR, Fiaux GW, Hulmes DJS, et al. Quantitative studies of human lung airspace wall in relation to collagen and elastin content. Matrix 1993; 13: 471-480.
71. Belton JC, Crise N, McLaughlin RF, et al. Ultrastructural alterations in collagen associated with microscopic foci of human emphysema. Hum Pathol 1977; 8: 669-677. (Pubitemid 8235755)
72. Wright JL, Churg A. Smoke-induced emphysema in the guinea pig is associated with morphometric evidence of collagen breakdown and repair. Am J Physiol 1995; 268: L17-L20.
73. Foronjy R, D'Armiento J. The role of collagenase in emphysema. Respir Res 2001; 2: 348-352. (Pubitemid 34189663)
74. D'Armiento J, Dalal SS, Okada Y, et al. Collagenase expression in the lungs of transgenic mice causes pulmonary emphysema. Cell 1992; 71: 955-961.
75. Goldin GV, Wessells NK. Mammalian, lung development: the possible role of cell proliferation in the formation of super-numerary tracheal buds and in branching morphogenesis. J Exp Zoo 1979; 208: 337-346.
76. Llinas L, Peinado VI, Goni JR, et al. Similar gene expression profiles in smokers and patients with moderate COPD. Pulm Pharmacol Ther 2011; 24: 32-41.
77. Selman M, Montano M, Ramos B, et al. Tobacco smoke-induced lung emphysema in guinea pigs is associated with increased interstitial collagenase. Am J Physiol 1996; 271: L734-L743.
78. Selman M, Cisneros-Lira J, Gaxiola M, et al. Matrix metalloproteinases inhibition attenuates tobacco smoke-induced emphysema in guinea pigs. Chest 2003; 123: 1633-1641. (Pubitemid 36549786)
79. Churg A, Wang RD, Tai H, et al. Tumor necrosis factor-α drives 70% of cigarette smoke-induced emphysema in the mouse. Am J Respir Crit Care Med 2004; 170: 492-498. (Pubitemid 39209129)
80. Mercer BA, Kolesnikova N, Sonett J, et al. Extracellular regulated kinase/mitogen activated protein kinase is up-regulated in pulmonary emphysema and mediates matrix metalloproteinase-1 induction by cigarette smoke. J Biol Chem 2004; 279: 17690-17696. (Pubitemid 38568101)
81. Mercer BA, Wallace AC, Brinckerhoff CE, et al. Identification of a cigarette smoke-responsive region in the distal MMP-1 promoter. Am J Respir Cell Mol Biol 2009; 40: 4-12.
82. Muroski ME, Roycik MD, Newcomer RG, et al. Matrix metalloproteinase -9/gelatinase B is a putative therapeutic target of chronic obstructive pulmonary disease and multiple sclerosis. Curr Pharm Biotechnol 2008; 9: 34-46. (Pubitemid 351266968)
83. Vornooy JHJ, Lindeman JHN, Jacobs JA, et al. Increased activity of matrix metalloproteinase -8 and matrix metalloproteinase -9 in induced sputum from patients with COPD. Chest 2004; 126: 1802-1810. (Pubitemid 39643983)
84. Omachi TA, Eisner MD, Rames A, et al. Matrix metalloproteinase-9 predicts pulmonary status declines in α1-antitrypsin deficiency. Respir Res 2011; 12: 35.
85. Culpitt SV, Rogers DF, Traves SL, et al. Sputum matrix metalloproteases: comparison between chronic obstructive pulmonary disease and asthma. Respir Med 2005; 99: 703-710. (Pubitemid 40631296)
86. Louhelainen N, Stark H, Mazur W, et al. Elevation of sputum matrix metalloproteinase-9 persists up to 6 months after smoking cessation: a research study. BMC Pulm Med 2010; 10: 13.
87. Segura-Valdes L, Pardo A, Gaxiola M, et al. Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPD. Chest 2000; 117: 684-694. (Pubitemid 30152206)
88. Lim S, Roche N, Oliver BG, et al. Balance of matrix metalloproteinase- 9 and tissue inhibitor of metalloprotease-1 from alveolar macrophages in cigarette smokers. Am J Respir Crit Care Med 2000; 162: 1355-1360.
89. Wang I-M, Stepaniants S, Boie Y, et al. Gene expression profiling inpatients with chronic obstructive pulmonary disease and lung cancer. Am J Respir Crit Care Med 2008; 177: 402-411. (Pubitemid 351317583)
90. Foronjy R, Nkyimbeng T, Wallace A, et al. Transgenic expression of matrix metalloproteinase-9 causes adult-onset emphysema in mice associated with the loss of alveolar elastin. Am J Physiol 2008; 294: L1149-L1157.
91. Kyriakides TR, Wulsin D, Skokos EA, et al. Mice that lack matrix metalloproteinase-9 display delayed wound healing associated with delayed reepithelization and disorded collagen fibrillogenesis. Matrix Biology 2009; 28: 65-73.
92. Atkinson JJ, Lutey BA, Suzuki Y, et al. The role of matrix metalloproteinase-9 in cigarette smoke-induced emphysema. Am J Respir Crit Care Med 2011; 183: 876-884.
93. March TH, Wilder JA, Esparza DC, et al. Modulators of cigarette smoke-induced pulmonary emphysema in A/J mice. Toxicol Sci 2006; 92: 545-559. (Pubitemid 44018971)
94. Ramos C, Cisneros J, Gonzalez-Avila G, et al. Increase of matrix metalloproteinases in woodsmoke-induced lung emphysema in guinea pigs. Inhal Toxicol 2009; 21: 119-132.
95. Lee EJ, In KH, Kim JH, et al. Proteomic analysis in lung tissue of smokers and COPD patients. Chest 2009; 135: 344-352.
96. Ilumets H, Rytila PH, Sovijarvi AR, et al. Transient elevation of neutrophil proteinases in induced sputum during COPD exacerbation. Scand J Clin Lab Invest 2008; 68: 618-623.
97. van Diemen CC, Postma DS, Vonk JM, et al. A disintegrin and metalloprotease 33 polymorphisms and lung function decline in the general population. Am J Respir Crit Care Med 2005; 172: 329-333. (Pubitemid 41026143)
98. Gosman MM, Boezen HM, van Diemen CC, et al. A disintegrin and metalloprotease 33 and chronic obstructive pulmonary disease pathophysiology. Thorax 2007; 62: 242-247. (Pubitemid 46579805)
99. Sadeghnejad A, Ohar JA, Zheng SL, et al. Adam33 polymorphisms are associated with COPD and lung function in long-term tobacco smokers. Respir Res 2009; 10: 21.
100. Culpitt SV, Maziak W, Loukidis S, et al. Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2011; 1999: 1630-1635.
101. Choe KH, Taraseviciene-Stewart L, Scerbavicius R, et al. Methylprednisolone causes matrix metalloproteinase-dependent emphysema in adult rats. Am J Respir Crit Care Med 2003; 167: 1516-1521. (Pubitemid 37363361)
102. Pemberton PA, Cantwell JS, Kim KM, et al. An inhaled matrix metalloprotease inhibitor prevents cigarette smoke-induced emphysema in the mouse. COPD 2005; 2: 303-310. (Pubitemid 43879446)
103. Martin RL, Shapiro SD, Tong SE, et al. Macrophage metalloelastase inhibitors. In: Hansel TT, Barnes PJ, eds. New Drugs for Asthma, Allergy and COPD. Basel, Progress in Respiratory Research, 2001; pp. 177-180.
104. Tuder RM, McGrath S, Neptune E. The pathobiological mechanisms of emphysema models: what do they have in common?Pulm Pharmacol Ther 2003; 16: 67-78. (Pubitemid 36369397)
105. McQuibban GA, Gong JH, Tam EM, et al. Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. Science 2000; 289: 1202-1206. (Pubitemid 30650734)
106. Lagente V, Le Quement C, Boichot E. Macrophage metalloelastase (MMP-12) as a target for inflammatory respiratory diseases. Expert Opin Ther Targets 2009; 13: 287-295.
107. Lavigne MC, Eppihimer MJ. Cigarette smoke condensate induces MMP-12 gene expression in airway-like epithelia. Biochem Biophys Res Commun 2005; 330: 194-203. (Pubitemid 40394952)
108. Betsuyaku T, Fukuda Y, Parks WC, et al. Gelatinase B is required for alveolar bronchiolization after intratracheal bleomycin. Am J Pathol 2000; 157: 525-535. (Pubitemid 30626912)
109. López-Boado YS, Li JU, Clayton CL, et al. Modification of the rat airway explant transcriptome by cigarette smoke. Inhal Toxicol 2010; 22: 234-244.
110. Wang RD, Wright JL, Churg A. Transforming growth factor-β1 drives airway remodeling in cigarette smoke-exposed tracheal explants. Am J Respir Cell Mol Biol 2005; 33: 387-393. (Pubitemid 41416289)
111. Lagente V, Manoury B, Nénan S, et al. Role of matrix metalloproteinases in the development of airway inflammation and remodeling. Braz J Med Biol Res 2005; 38: 1521-1530. (Pubitemid 41440223)
112. Masumoto K, de Rooij JD, Suita S, et al. Expression of matrix metalloptoteinases and tissue inhibitors of metalloptoteinases during normal human pulmonary development. Histopathol 2005; 47: 410-419. (Pubitemid 41428490)
113. Sprague AH, Khalil RA. Inflammatory cytokines in vascular dysfunction and vascular disease. Biochem Pharm 2009; 78: 539-552.
114. Hassoun PM, Mouthon L, Barbera JA, et al. Inflammation, growth factors, and pulmonary vascular remodeling. J Am Coll Cardiol 2009; 54: Suppl. S, S10-S19.
115. Li M, Li Z, Sun X. Statins suppress MMP2 secretion via inactivation of RhoA/ROCK pathway in pulmonary vascular smooth muscles cells. Eur J Pharmacol 2008; 591: 219-223.
116. Shah DI, Singh M. Involvement of Rho-kinase in experimental vascular endothelial dysfunction. Mol Cell Biochem 2006; 283: 191-199.
117. McMurtry IF, Abe K, Ota H, et al. Rho kinase-mediated vasoconstriction in pulmonary hypertension. Adv Exp Med Biol 2010; 661: 299-308.
118. Michelakis ED, Wilkins MR, Rabinovitch M. Emerging concepts and translational priorities in pulmonary arterial hypertension. Circulation 2008; 118: 1486-1495.
119. Cowan KN, Heilbut A, Humpl T, et al. Complete reversal of fatal pulmonary hypertension in rats by a serine elastase inhibitor. Nat Med 2000; 6: 698-702. (Pubitemid 30398796)
120. Cowan KN, Jones PL, Rabinovitch M. Elastase and matrix metalloproteinase inhibitors induce regression, and tenascin-C antisense prevents progression, of vascular disease. J Clin Invest 200, 105: 21-34.
121. Arciniegas E, Frid MG, Douglas IS, et al. Perspectives on endothelial-to-mesenchymal transition: potential contribution to vascular remodeling in chronic pulmonary hypertension. Am J Physiol 2007; 293: L1-L8. (Pubitemid 47080705)
122. Wright JL, Tai H, Wang R, et al. Cigarette smoke upregulates pulmonary vascular matrix metalloproteinases via TNF α signaling. Am J Physiol 2006; 292: L125-L133. (Pubitemid 46103438)
123. Vignola AM, Riccobono L, Mirabella A, et al. Sputum metalloproteinase-9/ tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis. Am J Respir Crit Care Med 1999; 158: 1945-1950. (Pubitemid 29008837)
124. Stevenson CS, Coote K, Webster R, et al. Characterization of cigarette smoke-induced inflammatory andmucus hypersecretory changes in rat lung and the role of CXCR2 ligands in mediating this effect. Am J Physiol Lung Cell Mol Physiol 2005; 288: L514-L522. (Pubitemid 40229517)
125. Stevenson CS, Docx C, Webster R, et al. Comprehensive gene expression profiling of rat lung reveals distinct acute and chronic responses to cigarette smoke inhalation. Am J Physiol 2007; 293: L1183-L1193. (Pubitemid 350159403)
126. Takeyama K, Dabbagh K, Lee H-M, et al. Epidermal growth factor system regulates mucin production in airways. Proc Natl Acad Sci USA 1999; 96: 3081-3086. (Pubitemid 29148847)
127. Deshmukh HS, Case LM, Wesselkamper SC, et al. Metalloproteinases mediate mucin 5AC expression by epidermal growth factor receptor activation. Am J Respir Crit Care Med 2005; 171: 305-314. (Pubitemid 40223396)
128. Zhu Z, Homer RJ, Wang Z, et al. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 1999; 103: 779-788. (Pubitemid 29152623)
129. Ren S, Guo LL, Yang J, et al. Doxycycline attenuates acrolein-induced mucin production, in part by inhibiting MMP-9. Eur J Pharmacol 2011; 650: 418-423.
130. Liu DS, Wang T, Han SX, et al. P38 MAPK and MMP-9 cooperatively regulate mucin overproduction in mice exposed to acrolein fog. Int Immunopharmacol 2009; 10: 1228-1235.
131. Kim JH, Lee SY, Bak SM, et al. Effects of matrix metalloproteinase inhibitor on LPS-induced goblet cell metaplasia. Am J Physiol Lung Cell Mol Physiol 2004; 287: L127-L133. (Pubitemid 38787659)